Biodegradable Multi-Block Copolymers for Drug Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current biodegradable polymers used in drug delivery systems, such as PLGA and PDLLA, face limitations due to their high glass transition temperatures, leading to rigid matrices that restrict drug release and can be detrimental to sensitive compounds like proteins and peptides, and are challenging to process into free-flowing microspheres.
Innovation Solution
Development of biodegradable multi-block copolymers with segments of different chemical compositions and physicochemical properties, linked by a multifunctional chain-extender, allowing for controlled permeability and degradation rates to achieve tunable release profiles and phase separation for biphasic drug release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If conventional biodegradable polymers like PLGA and PDLLA are used, then biodegradability and drug delivery functionality are achieved, but the high glass transition temperature causes rigid matrices that restrict drug release and are difficult to process into free-flowing microspheres
Solution Approach 1:
The polymer chain is segmented into multiple blocks with different chemical compositions and properties. Each block can be optimized for specific functions: some blocks provide flexibility and low Tg for ease of processing, while others provide structural integrity and controlled degradation. This segmentation allows the material to exhibit both low glass transition temperature for processability and high biodegradability for drug delivery.
Solution Approach 2:
The invention creates a composite polymer structure combining multiple polymer blocks with different characteristics. The composite nature allows the material to simultaneously achieve low glass transition temperature (from flexible blocks) and high biodegradability (from hydrolyzable blocks), resolving the contradiction between processability and functional performance.
2Reliability
If conventional biodegradable polymers are used, then biodegradability is achieved, but the rigid matrix structure limits controlled release of therapeutic agents
Solution Approach 1:
The polymer matrix is segmented into blocks with different mechanical and degradation properties. Flexible blocks create channels and pathways for drug diffusion, while more rigid blocks maintain structural integrity. This segmentation enables controlled release by allowing drug molecules to navigate through the flexible segments while the overall matrix remains sufficiently rigid to maintain its form.
Solution Approach 2:
Different regions of the polymer matrix have different local properties. Some blocks provide high flexibility and porosity for enhanced drug release, while other blocks provide structural stability. This local variation in quality allows simultaneous achievement of controlled release and matrix strength.
3Adaptability or versatility
If multi-block copolymers with different segments are used, then tunable release profiles and phase separation are achieved, but the complexity of controlling segment composition and ratio increases
Solution Approach 1:
The polymer is divided into discrete blocks that can be independently designed and controlled. Each block's composition, length, and arrangement can be tuned to achieve desired release profiles. The modular nature of segmentation allows systematic control of segment composition without requiring complex synthesis procedures.
Solution Approach 2:
The invention utilizes parameter changes in segment composition, block length, and arrangement to tune the release profile. By adjusting these parameters, the material can be optimized for different drug types and delivery requirements. The systematic approach to parameter variation simplifies the control process compared to random copolymer synthesis.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The multi-block copolymers provide flexible and non-sticky materials for drug delivery, enabling controlled and optimized release of therapeutic agents, reducing tissue irritation and improving the handling and efficacy of drug-loaded microspheres and coatings.
Implementation Method 1
the segments being linked by a multifunctional chain-extender
Implementation Method 2
the hydrolysable sequences being amorphous
Data Source
AI summary
The invention relates to a biodegradable multi-block copolymer, comprising at least two hydrolysable segments derived from pre-polymers A and B, which segments are linked by a multi-functional chain-extender and are chosen from the pre-polymers A and B, and triblock copolymers ABA and BAB, wherein the multi-block copolymer is amorphous at physiological (body) conditions. The invention further relates to a process for preparing said copolymer and to its use as a medical implant, a coating for a medical device or a drug delivery vehicle.